Profile data is unavailable for this security.
About the company
Supergenics Berhad is a Malaysia-based management and investment holding company. The Company operates through three segments: Integrated Turnkey Solutions, Biomedical, and Investment Holding. Its Integrated Turnkey Solutions segment is engaged in the provision of integrated turnkey solutions for the related development of cleanrooms and the provision of related maintenance services. Its Biomedical segment is engaged in the provision of administrative health care services, operating medical laboratories, and developing regenerative wellness products. The Company provides laboratory services, including storage and handling of stem cell samples. Its services include stem cells, mesenchymal stem cells (MSC), natural killer (NK) cells, exosomes, and MSC exosomes. Its subsidiaries include Supergenics Solution Sdn. Bhd., Supergenics Life Science Sdn. Bhd., Supergenics Therapeutic Sdn. Bhd., Supergenics Bio Agro Sdn. Bhd., Supergenics Stembank Sdn. Bhd., and Supergenics Global Sdn. Bhd.
- Revenue in MYR (TTM)6.39m
- Net income in MYR-6.26m
- Incorporated2016
- Employees9.00
- LocationSupergenics BhdSuite A-01-03The Place @ One City, Jalan, USJ 25/1A,SELANGOR DARUL EHSAN 47650MalaysiaMYS
- Phone+60 351150437
- Websitehttps://www.supergenic.com.my/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nexalis Therapeutics Ltd | 2.34m | -3.70m | 18.35m | -- | -- | -- | -- | 7.86 | -0.006 | -0.006 | 0.0037 | -0.0041 | 0.8301 | -- | 2.50 | -- | -131.43 | -73.85 | -- | -100.32 | -- | -- | -158.33 | -369.19 | -- | -- | -- | -- | -66.38 | 21.67 | 16.21 | -- | -- | -- |
| Biotron Ltd | 0.00 | -888.37k | 18.84m | 4.00 | -- | 6.01 | -- | -- | -0.0004 | -0.0004 | 0.00 | 0.0004 | 0.00 | -- | -- | -- | -43.23 | -86.63 | -206.95 | -112.69 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 90.73 | -- | -- | -- |
| Invion Ltd | 0.00 | -24.56m | 18.87m | 8.00 | -- | 0.8127 | -- | -- | -0.1183 | -0.1183 | 0.00 | 0.0972 | 0.00 | -- | -- | -- | -70.63 | -29.16 | -77.64 | -30.88 | -- | -- | -- | -147.34 | -- | -- | 0.00 | -- | -100.00 | -- | -56.50 | -- | -- | -- |
| Vectus Biosystems Ltd | 52.34k | -4.96m | 19.37m | -- | -- | -- | -- | 370.08 | -0.0334 | -0.0334 | 0.0004 | -0.0048 | 0.0134 | -- | 0.0266 | -- | -126.57 | -79.19 | -247.24 | -189.44 | -- | -- | -9,468.62 | -10,165.01 | 0.9301 | -554.06 | -- | -- | -75.58 | 73.61 | 23.99 | -- | -- | -- |
| Percheron Therapeutics Ltd | 1.03m | -41.61m | 21.23m | 8.00 | -- | 0.7609 | -- | 20.51 | -0.0149 | -0.0149 | 0.0004 | 0.0092 | 0.0275 | -- | 0.2824 | -- | -110.67 | -79.28 | -153.98 | -96.61 | -- | -- | -4,021.00 | -3,694.96 | -- | -1,093.50 | 0.0026 | -- | -39.71 | 64.80 | -25.19 | -- | -6.74 | -- |
| Chimeric Therapeutics Ltd | 11.07m | -29.09m | 24.64m | -- | -- | 2.14 | -- | 2.23 | -0.007 | -0.007 | 0.0028 | 0.0009 | 0.2154 | -- | 1.73 | -- | -56.62 | -66.67 | -171.92 | -112.02 | 78.66 | -- | -262.83 | -2,013.07 | -- | -62.30 | 0.7162 | -- | -- | -- | 16.76 | -- | -- | -- |
| Invex Therapeutics Ltd | 1.32m | -2.33m | 25.15m | -- | -- | 1.98 | -- | 19.05 | -0.0111 | -0.0111 | 0.0063 | 0.0605 | 0.0894 | -- | 5.09 | -- | -15.79 | -15.04 | -16.83 | -15.74 | -- | -- | -176.61 | -419.12 | -- | -- | 0.00 | -- | -72.92 | 22.74 | 70.95 | -- | -- | -- |
| Imagion Biosystems Ltd | 2.94m | -6.14m | 27.36m | -- | -- | -- | -- | 9.29 | -0.0177 | -0.0177 | 0.0082 | -0.0192 | 1.45 | -- | 1,173.13 | -- | -302.58 | -76.63 | -- | -102.36 | -- | -- | -208.52 | -911.24 | -- | -0.7972 | -- | -- | -18.54 | 22.02 | 83.43 | -- | -- | -- |
| Supergenics Bhd | 6.39m | -6.26m | 29.11m | 9.00 | -- | 8.67 | -- | 4.55 | -0.0541 | -0.0541 | 0.0553 | 0.0288 | 0.3854 | -- | 1.48 | -- | -40.11 | -13.47 | -67.83 | -21.06 | 43.76 | 34.41 | -104.07 | -24.19 | -- | -15.68 | 0.6413 | -- | -48.02 | -13.53 | -4,216.70 | -- | 77.38 | -- |
| BPH Energy Ltd | 2.55m | -3.37m | 30.20m | 2.00k | -- | 0.2569 | -- | 11.85 | -0.001 | -0.001 | 0.0008 | 0.0311 | 0.0235 | -- | 8.56 | -- | -3.10 | 9.05 | -3.15 | 9.45 | -- | -- | -132.17 | 431.04 | -- | -0.8233 | 0.0022 | -- | -0.8344 | 28.34 | 48.93 | 43.33 | -- | -- |
| Cambium Bio Ltd | 2.01m | -9.97m | 31.38m | -- | -- | 4.35 | -- | 15.64 | -0.2766 | -0.2766 | 0.0455 | 0.1126 | 0.2011 | -- | 4.09 | -- | -99.90 | -41.30 | -150.85 | -75.44 | 70.61 | -- | -496.86 | -118.71 | -- | -- | 0.1378 | -- | 419.43 | -16.63 | -70.42 | -- | -- | -- |
| Adalta Ltd | 1.75m | -12.17m | 35.55m | -- | -- | -- | -- | 20.34 | -0.0039 | -0.0039 | 0.0005 | -0.0001 | 0.2993 | -- | 1.70 | -- | -208.36 | -70.41 | -611.82 | -126.24 | -- | -- | -696.16 | -207.18 | -- | -15.14 | -- | -- | -61.02 | -28.97 | 16.33 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Phillip Capital Management Sdn. Bhd.as of 30 Jun 2025 | 750.00k | 0.64% |
